Tue, October 13, 2020 11:00 AM - Tue, October 13, 2020 12:00 PM at ZOOM ONLY
https://msu.zoom.us/j/99065828766?pwd=ZlRDT0RHZ3JOMWVyVGczOEZWTjF0QT09
Learning Objectives: At the completion of this activity, participants will be able to:
1. Identify factors associated with poor patient outcomes
2. Explain the theoretical advantage of proning in patients with severe lung injury due to COVID-19
3. Discuss the evidence on the use of corticosteroids in patients with severe lung injury due to COVID-19
4. Discuss the evidence on the use of remdesevir in patients with COVID-19
5. Interpret evidence on convalescent plasma & tocilizumab for treating COVID-19 patients